Funded by the EU H2020, ENLIGHT researchers will develop a living model of the pancreas to enable better testing of diabetes medication. This model is manufactured using a new method of bioprinting invented at the UMC Utrecht and EPFL (École polytechnique fédérale de Lausanne), and specialized stem cells studied by ETH Zürich and the University of Naples Federico II
Project Coordinator: Riccardo Levato: “With eight European partners, we will now develop a new bioprinter that, using visible light, prints stem cells three-dimensionally into functional pancreatic tissues.”
ENLIGHT has received a 4-year grant from the European innovation Council fund Horizon 2020 under grant agreement 945119. The aim is to realize the first working tissue model within three years.
Read more about the project here:
https://lnkd.in/gbpuVXi
Company Details
- Founded
- -
- Address
- Utrecht, Nl
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://enlightproject.eu
- Keywords
- ENable LIGHT- and synthetic biology-driven volumetric bioprinting of functional human tissues.
- HQ
- Utrecht
Enlight Questions
Enlight's website is http://enlightproject.eu
Enlight's LinkedIn profile is https://nl.linkedin.com/company/enlight-h2020
Enlight's industry is
Research Services
Enlight's top competitors are
Smarts-Projects,
Opix Pc,
Filantropia D'impresa,
Germe La Rochelle Groupe Rebelle,
West Side Community Fund,
B-Brighter,
Upgrade School Marketing,
Yocca Playgrounds + Outdoor Fitness,
Euclid Consortium,
Prism-Lt.
Enlight's categories are Research Services
Enlight's founding year is 2021
